PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New tablet shows promise for the control and elimination of intestinal worms

The ALIVE clinical trial shows that a tablet combining albendazole and ivermectin is safe and more effective than albendazole alone in treating soil-transmitted helminths

2025-01-11
(Press-News.org) A new tablet combining albendazole and ivermectin is safe and more effective than albendazole alone in treating Trichuris trichiura and other soil-transmitted helminths (STH), according to a clinical trial conducted by the STOP consortium and led by the Barcelona Institute of Global Health (ISGlobal), a centre supported by “la Caixa” Foundation. The findings, published in The Lancet Infectious Diseases, open opportunities to improve the control of these neglected tropical infections, which affect around 1.5 billion people worldwide.

Soil-transmitted helminthiases (STH) are caused by four species of parasitic worms (Ascaris lumbricoides, Trichuris trichiura, and the hookworms Ancylostoma duodenale and Necator americanus) that are transmitted through contact with contaminated soil or water. They have a significant impact on nutrition and health, particularly in children and women of reproductive age living in endemic areas of Latin America, Asia and sub-Saharan Africa.

The current STH control strategy relies on regular deworming treatments with albendazole for at-risk populations, along with improvements in water, sanitation, and hygiene. Albendazole is highly efficient against Ascaris but its efficacy against T. trichiura has been declining, probably due to emerging drug resistance. Additionally, albendazole is not effective against Strongyloides stercoralis, another helminth that has been added to the list of intestinal parasites requiring control measures.

A new tablet To address these gaps, the EDCTP-funded STOP consortium tested an innovative tablet combining a fixed dose of albendazole and ivermectin. Ivermectin has been shown to be more effective against T. trichiura when combined with albendazole, and is the drug of choice to treat S. stercoralis and other parasitic infections.

“This fixed-dose co-formulation (FDC) has several advantages. It is easy to administer, as it is one single pill and does not require dose adjustments based on the child’s weight,” explains project leader Jose Muñoz, ISGlobal researcher and Head of the International Health Service at Hospital Clinic Barcelona. “Also, we hope that combining two drugs with different mechanisms of action will reduce the risk of the parasites becoming drug-resistant,” he adds.

One clinical trial in three African countries The ALIVE clinical trial, conducted in Ethiopia, Kenya and Mozambique, tested the safety and efficacy of the FDC in school-aged children (aged 5 to 18 years) infected with T. trichiura, hookworms, S. stercoralis or a combination. The children were randomly divided into three treatment groups: group 1 received a single dose of albendazole; group 2 received one dose of the FDC (FDCx1); and group 3 received three doses of the FDC (FDCx3) over three consecutive days.

Safety first Phase 2 of the trial focused on safety. A small number of participants were recruited and treated sequentially according to weight, to monitor any adverse effects caused by higher-than-usual doses of ivermectin (above 200 µg/ml). No serious adverse effects were observed, and side effects were similar to those in the albendazole group. This allowed the trial to proceed to phase 3, where efficacy was assessed in a much larger number of participants, alongside continued safety monitoring.

In total, 4,353 children were screened for STH infections and 1,001 were randomised for treatment. Of those infected, 63% were positive for T. trichiura, 36% for hookworms and 10% for S. stercoralis.

Higher efficacy against T. trichiura and hookworms Treatment efficacy was assessed based on cure rates (absence of eggs in stool samples post-treatment) and reduction in the number of eggs in stool compared to before the treatment. For T. trichiura, the FDC achieved higher cure rates at both regimens (97% for FDCx3, 83% for FDCx1) compared to albendazole alone (36%). For hookworms, the FDCx3 regimen showed a higher cure rate (95%), while the FDCx1 regimen was similar to albendazole (79% and 65% respectively). For S. stercoralis, the sample size was too small to assess efficacy, but the existing evidence suggests that the FDC would also be more effective, since ivermectin is far more effective than albendazole against this parasite.

Although most infections were classified as light, both FDC regimens achieved higher egg reduction rates than albendazole alone.

Implications for public health “This is a pivotal trial that opens up the possibility of controlling all species of STH, including Strongyloides, and may lead to reconsider elimination goals that were deemed unattainable with albendazole alone,” says Alejandro Krolewiecki, clinical trial coordinator. The next step is to conduct larger-scale studies, such as the ongoing trial led by STOP2030, to further evaluate the safety of the FDC in the context of mass deworming campaigns.

Defining optimal implementation strategies will also be essential if the FDC is to be adopted by national programmes. The trial findings suggest that a single-dose regimen of the FDC may be simple to apply in mass deworming activities, while the three-day regimen, which offers superior efficacy, may be better for individual treatment decisions, or for programmes aiming to completely eliminate STH from the population.

"With its child-friendly formulation – orodispersable and mango-flavored - and its high acceptance, this tablet holds great potential for advancing health outcomes in regions affected by these diseases," says Stella Kepha, researcher from the Kenya Medical Research Institute (KEMRI).


Reference

Krolewiecki A, Kepha S, Fleitas PE et al. Albendazole–ivermectin co-formulation for the treatment of Trichuris trichiura and other soil-transmitted helminths: a randomised phase 2/3 trial. The Lancet Infectious Diseases. https://doi.org/10.1016/S1473-3099(24)00669-8 


Funder

The STOP project was supported by the EDCTP2 program (grant number RIA2017NCT-1845 and PSIA2020-3072) www.stoptheworm.org

END


ELSE PRESS RELEASES FROM THIS DATE:

Project to redesign clinical trials for neurologic conditions for underserved populations funded with $2.9M grant to UTHealth Houston

Project to redesign clinical trials for neurologic conditions for underserved populations funded with $2.9M grant to UTHealth Houston
2025-01-10
In an effort to close the gap in neurological outcomes for underserved populations, a UTHealth Houston project funded with $2.9 million from the National Institutes of Health (NIH) will engage community partners to improve the design of clinical trials. Neurologic conditions including stroke, Parkinson’s disease, and vascular cognitive impairment and dementia contribute to the leading causes of death and disability in the U.S. The goal of the project is to build an infrastructure for community-engaged research interventions for those three neurologic conditions affecting brain health. “Historically, clinical trials for neurological conditions haven’t ...

Depression – discovering faster which treatment will work best for which individual

2025-01-10
Depression can affect anyone. It is common, and in many cases severe. These days, there are good treatments available, typically involving a combination of psychotherapy and medication. However, finding the right treatment can take some time. Not everyone responds equally well to every medication. Researchers at six European university medical centers, led by Charité – Universitätsmedizin Berlin, teamed up to accelerate the process of arriving at solid findings relating to both new and known treatments. The key will be a joint study design, supported over the ...

Breakthrough study reveals unexpected cause of winter ozone pollution

2025-01-10
Researchers from the Hong Kong Polytechnic University, alongside mainland collaborators, have uncovered an unexpected phenomenon: severe wintertime ozone (O₃) pollution in Lanzhou, China, driven primarily by alkene emissions from local petrochemical industries. Traditionally associated with warm weather and strong solar radiation, hourly O₃ levels exceeding 100 ppbv were recorded during cold January days in 2018, peaking at an alarming 121 ppbv.   Using an advanced photochemical box model, the study identified alkene ozonolysis as ...

nTIDE January 2025 Jobs Report: Encouraging signs in disability employment: A slow but positive trajectory

nTIDE January 2025 Jobs Report: Encouraging signs in disability employment: A slow but positive trajectory
2025-01-10
East Hanover, NJ – January 10, 2025 – The employment-to-population ratio for people with disabilities has remained stable over the past 15 months amid historically high levels, with recent data suggesting a modest but encouraging upward trend, according to today’s January 2025 National Trends in Disability Employment monthly update (nTIDE) issued by Kessler Foundation and the University of New Hampshire’s Institute on Disability (UNH-IOD). Month-to-Month nTIDE Numbers (comparing November 2024 to December 2024) Based on data from the U.S. Bureau of Labor Statistics (BLS) ...

Generative AI: Uncovering its environmental and social costs

2025-01-10
A recent commentary article by researchers from Northwestern University, Harvard University, and The University of Texas at San Antonio highlights the significant but overlooked environmental and social impacts of Generative Artificial Intelligence (GenAI). Published in Environmental Science and Ecotechnology, the research underscores the urgent need for sustainable practices and ethical governance as GenAI technologies proliferate.   The study reveals the environmental toll of GenAI development, with hardware production such as GPUs and data centers consuming ...

Lower access to air conditioning may increase need for emergency care for wildfire smoke exposure

2025-01-10
FOR IMMEDIATE RELEASE  January 10, 2025  Contact: Jillian McKoy, jpmckoy@bu.edu Michael Saunders, msaunder@bu.edu ## Lower Access to Air Conditioning May Increase Need for Emergency Care for Wildfire Smoke Exposure As Los Angeles County battles the most destructive wildfires in its history, a new study suggest that US policies should prioritize equity and education regarding the measures people can take to protect themselves from the harmful pollutants in wildfire smoke.  People who have limited access to air ...

Dangerous bacterial biofilms have a natural enemy

Dangerous bacterial biofilms have a natural enemy
2025-01-10
If your teeth have ever felt fuzzy after skipping a brushing, you’ve encountered biofilm—a slimy bacterial layer that clings to surfaces. In medical settings, biofilms make infections harder to treat when they form protective shields for bacteria on devices like catheters and implants.  UC Riverside scientists have now discovered a chemical that plants produce when they're stressed prevents biofilm from forming. The breakthrough offers potential advances in healthcare as well as preventing equipment corrosion in industrial settings.  “In simple terms, biofilms are communities ...

Food study launched examining bone health of women 60 years and older

2025-01-10
Hinda and Arthur Marcus Institute for Aging Research investigators at Hebrew SeniorLife have launched a large clinical food trial to test whether a combination of probiotics and prebiotics (BondiaÒ or SBD111) developed by Solarea Bio will help manage bone health in women aged 60 years and above. The first participants have joined the study and the Institute seeks additional women for the 18-month effort.   “I am very happy to be involved in this important research to help with bone health in women,” says study participant Kathy ...

CDC awards $1.25M to engineers retooling mine production and safety

CDC awards $1.25M to engineers retooling mine production and safety
2025-01-10
From mapping ore to predicting slope behavior and reclaiming land, mining is a rapidly evolving technological industry. Yet planning and operations have not necessarily kept up with the advancements.  With $1.25 million from the National Institute for Occupational Safety and Health, or NIOSH, mining and geological engineering researchers in the University of Arizona College of Engineering are boosting their efforts to better align technology and planning for improved safety and productivity. The award from the institute, part of the Centers for Disease Control and Prevention, will fund the research ...

Using AI to uncover hospital patients’ long COVID care needs

2025-01-10
PHILADELPHIA— Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may seem universal, the reality is that there are nuances that require individual attention, both in the make-up of the patients being seen and the situations of the hospitals providing their care. New research shows that artificial intelligence can potentially help improve care overall by combing through ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] New tablet shows promise for the control and elimination of intestinal worms
The ALIVE clinical trial shows that a tablet combining albendazole and ivermectin is safe and more effective than albendazole alone in treating soil-transmitted helminths